The Gay, Lesbian, Bisexual and Transgender Community Center of Baltimore and Central Maryland (GLCCB) will host a town hall panel and discussion on April 28 on the use of Pre-Exposure Prophylaxis (PrEP)— an HIV prevention method in which people who do not have HIV take a daily pill to reduce their risk of becoming infected.
“The use and effects of PrEP still remain a mystery to many in our community,” GLCCB board member Chris Adkins said in a statement. “This month’s town hall is designed to allow for an open dialogue between community members and health care professionals to educate, clarify, and demystify the use of this often misunderstood HIV prevention method.”
The town hall will be held in the Mason Lord Room of the Waxter Center from 7-9 p.m. and will feature guest speakers Deb Dun of Chase Brexton Health Services; Brian M. Palmer of Gilead Sciences, Inc.; Dr. Renata Arrington-Sanders of Johns Hopkins Hospital; and Dr. Patrick Ryscavage of University of Maryland Medical Center.
The panel will address the risks and benefits of the medication, accessing health insurance and co-pay assistance programs needed to cover the costs, and ways to access medication in Baltimore. Additionally, HIV testing will be offered and local physicians will be available to answer any related questions.
Pre-Exposure Prophylaxis (PrEP) is a medical protocol that is designed to treat people who have not been exposed to specific diseases, but are at high risk of contracting them.